跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Claritrox Granules for Oral suspension 125mg/5ml - NPRA Drug Approval Details
Approvals
/
NPRA
/
Claritrox Granules for Oral suspension 125mg/5ml
Approved
STANDARD
Claritrox Granules for Oral suspension 125mg/5ml
SM PHARMACEUTICALS SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
b90e90d106f7def4
Company
SM PHARMACEUTICALS SDN. BHD.
Type
Standard
Approval Details
Approval Id
b90e90d106f7def4
Drug Approval Npra Name
Claritrox Granules for Oral suspension 125mg/5ml
Product Name
Claritrox Granules for Oral suspension 125mg/5ml
Registration Number
MAL24086020AZ
Holder Company Name
SM PHARMACEUTICALS SDN. BHD.
Holder Address
LOT 88, SUNGAI PETANI INDUSTRIAL ESTATE, 08000 SUNGAI PETANI MALAYSIA
Holder Phone
04-4411801
Manufacturer Company Name
SM PHARMACEUTICALS SDN. BHD.
Manufacturer Address
LOT 88 SUNGAI PETANI INDUSTRIAL ESTATE 08000 SUNGAI PETANI MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL24086020AZ
Version
1751614227
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
b90e90d106f7def4
Type
Standard
Source
Official Source
Back to NPRA Approvals